Hirotomo Harimoto

438 total citations
10 papers, 335 citations indexed

About

Hirotomo Harimoto is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Hirotomo Harimoto has authored 10 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Hirotomo Harimoto's work include Liver Disease and Transplantation (4 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (3 papers). Hirotomo Harimoto is often cited by papers focused on Liver Disease and Transplantation (4 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (3 papers). Hirotomo Harimoto collaborates with scholars based in Japan. Hirotomo Harimoto's co-authors include Katsuhisa Nakatsuka, Choitsu Sakamoto, Masanori Atsukawa, Masumi Shimizu, Hidemi Takahashi, Hideko Kidokoro, Takeshi Fukuda, Yoshiyuki Narahara, Hidenori Kanazawa and Yoko Matsushita and has published in prestigious journals such as Gastroenterology, PLoS ONE and Immunology.

In The Last Decade

Hirotomo Harimoto

10 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirotomo Harimoto Japan 6 214 184 127 93 61 10 335
Tamás Tornai Hungary 12 211 1.0× 207 1.1× 79 0.6× 58 0.6× 16 0.3× 26 344
Gerasimos Baltayiannis Greece 11 207 1.0× 196 1.1× 72 0.6× 25 0.3× 65 1.1× 23 331
Julien Vionnet Switzerland 11 133 0.6× 80 0.4× 127 1.0× 48 0.5× 30 0.5× 35 313
Abdelrahman Kobtan Egypt 10 256 1.2× 223 1.2× 120 0.9× 32 0.3× 34 0.6× 26 387
Ashesh P. Shah United States 12 167 0.8× 101 0.5× 227 1.8× 40 0.4× 43 0.7× 31 460
Vincenzo Ronca Italy 14 310 1.4× 195 1.1× 248 2.0× 68 0.7× 39 0.6× 32 472
Ramazan Uçar Türkiye 10 70 0.3× 98 0.5× 85 0.7× 73 0.8× 74 1.2× 29 322
Valentina Monti Italy 9 195 0.9× 195 1.1× 91 0.7× 19 0.2× 41 0.7× 17 350
Ruey‐Shyang Soong Taiwan 12 151 0.7× 104 0.6× 187 1.5× 49 0.5× 48 0.8× 32 355
Yushu Shang China 8 219 1.0× 143 0.8× 184 1.4× 20 0.2× 63 1.0× 10 369

Countries citing papers authored by Hirotomo Harimoto

Since Specialization
Citations

This map shows the geographic impact of Hirotomo Harimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotomo Harimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotomo Harimoto more than expected).

Fields of papers citing papers by Hirotomo Harimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotomo Harimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotomo Harimoto. The network helps show where Hirotomo Harimoto may publish in the future.

Co-authorship network of co-authors of Hirotomo Harimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotomo Harimoto. A scholar is included among the top collaborators of Hirotomo Harimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotomo Harimoto. Hirotomo Harimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Harimoto, Hirotomo, Hidenori Kanazawa, Yoshiyuki Narahara, et al.. (2020). Transjugular intrahepatic portosystemic shunt for the treatment of refractory hepatic hydrothorax. Kanzo. 61(8). 399–409. 1 indexed citations
2.
Hayama, Korenobu, Keiko Kaneko, Hirotomo Harimoto, et al.. (2019). Tu1511 – The Add-On Effect of At-Iii in Thrombolytic Therapy for Portal Vein Thrombosis. Gastroenterology. 156(6). S–1348. 1 indexed citations
3.
4.
Harimoto, Hirotomo, Masumi Shimizu, Yohko Nakagawa, et al.. (2013). Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells. Immunology and Cell Biology. 91(10). 665–665. 1 indexed citations
5.
Harimoto, Hirotomo, Masumi Shimizu, Yohko Nakagawa, et al.. (2013). Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells. Immunology and Cell Biology. 91(9). 545–555. 89 indexed citations
6.
Nakatsuka, Katsuhisa, Masumi Shimizu, Hideto Tamura, et al.. (2012). Ribavirin modulates the conversion of human CD4+ CD25T cell to CD4+ CD25+ FOXP3+T cell via suppressing interleukin‐10‐producing regulatory T cell. Immunology. 137(3). 259–270. 18 indexed citations
7.
Atsukawa, Masanori, Katsuhisa Nakatsuka, K. Tamaki, et al.. (2011). Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin‐10 secretion to assist in hepatitis C virus clearance. Journal of Gastroenterology and Hepatology. 27(4). 823–831. 18 indexed citations
8.
Narahara, Yoshiyuki, Hidenori Kanazawa, Takeshi Fukuda, et al.. (2010). Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. Journal of Gastroenterology. 46(1). 78–85. 116 indexed citations
9.
Narahara, Yoshiyuki, Hidenori Kanazawa, Masanori Atsukawa, et al.. (2009). Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 24(11). 1791–1797. 81 indexed citations
10.
Kanazawa, Hidenori, Yoshiyuki Narahara, Takeshi Fukuda, et al.. (2009). [Transjugular intrahepatic portosystemic shunt for refractory ascites: results in 50 patients].. PubMed. 106(3). 356–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026